COVID-19 and venous thromboembolism: current insights and prophylactic strategies
- 13 July 2020
- journal article
- editorial
- Published by Taylor & Francis in Annals of Medicine
- Vol. 52 (6) , 239-242
Abstract
(2020). COVID-19 and venous thromboembolism: current insights and prophylactic strategies. Annals of Medicine. Ahead of Print.Keywords
This publication has 36 references indexed in Scilit:
- Anti-Xa assays: What is their role today in antithrombotic therapy?Cleveland Clinic Journal of Medicine, 2019
- Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant TreatmentJournal of the American Heart Association, 2018
- How I treat disseminated intravascular coagulationBlood, 2018
- Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolismJournal of Thrombosis and Thrombolysis, 2016
- Critical Care Rehabilitation—is it the Answer for Reducing Morbidity in ARDS Survivors? Regarding “Acute Respiratory Distress Syndrome: A Clinical Review”Pulmonary Circulation, 2012
- Prevention of VTE in Nonsurgical PatientsChest, 2012
- Functional Disability 5 Years after Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2011
- A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction ScoreJournal of Thrombosis and Haemostasis, 2010
- Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patientsBlood Coagulation & Fibrinolysis, 2009
- Comparative Pharmacokinetics of LMWHsSeminars in Thrombosis and Hemostasis, 2000